News & Updates

Increased triglycerides (TG)-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) appears to be associated with a markedly raised risk of stroke only among individuals with healthy body mass index (BMI), according to a study.

Patients with Parkinson’s disease dementia (PDD) who continued treatment with pimavanserin had a lower risk of psychosis relapse compared with those on placebo, according to a post hoc analysis of the HARMONY* trial presented at AAN 2022.

The risk of subclinical valve leaflet thrombosis (SLT) following transcatheter aortic valve replacement (TAVR) did not differ regardless of whether patients received edoxaban or dual antiplatelet therapy (DAPT) post-surgery, according to results of the ADAPT-TAVR* trial.

A long-term safety analysis of repeated diazepam nasal sprays finds acceptable rates of treatment-emergent adverse events in children and adolescents, with such side effects being comparably common between the two age groups.

Neurosurgery performed 2–4 hours after presenting to the emergency department (ED) seems to result in better survival outcomes in patients with spontaneous haemorrhagic stroke, reports a recent study.

Treatment with ravulizumab leads to rapid and sustained reductions in myasthenia gravis (MG) symptoms, according to the CHAMPION study presented at AAN 2022.